ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →

UBS Reshapes Chemicals, Ciena Gets Massive Upgrade

Edited by Peter Hillerberg1 min read

Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish

ShareXLinkedInReddit

UBS analyst Joshua Spector moved across the materials sector in a sweep of calls. He cut LyondellBasell to Hold from Buy, slashing the target to $73 from $82. He also trimmed Dow Inc. to Hold, lowering the target to $37 from $39. Both chemicals giants face margin pressure in a sluggish global cycle.

The UBS upgrade steal the show, however. Ciena Corporation got a dramatic target price lift to $508 from $285 — a 78% jump — as analyst David Vogt turned bullish on the networking hardware maker. Ciena's market cap sits near $75.8 billion. Short interest is a modest 3.1% of free float. That low short positioning leaves little friction for a rally.

lululemon athletica drew two separate downgrades in quick succession. UBS and Telsey Advisory Group both cut to Hold. Telsey slashed the price target to $122 from $175. The apparel brand faces slowing North American demand. Short interest at 6.2% of free float has room to grow if sentiment sours further.

On the consumer side, Walmart saw its consensus target tick up to $137.95. Separately, Medtronic saw its target trimmed to $98.58, reflecting caution in medtech ahead of a challenging reimbursement environment.

How this article was generated

Generated
6 Jun 2026, 04:20
Prompt version
v1.0
Data sources
Analyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.